Literature DB >> 1234375

Chemotherapy of melanoma.

J K Luce.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1234375

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  7 in total

1.  The use of regional chemotherapy in the management of malignant melanoma.

Authors:  E T Krementz; R D Carter; C M Sutherland; M Campbell
Journal:  World J Surg       Date:  1979-07-30       Impact factor: 3.352

2.  Neurocutaneous melanosis with associated Dandy-Walker complex.

Authors:  Adrian Caceres; Humberto Trejos
Journal:  Childs Nerv Syst       Date:  2004-10-01       Impact factor: 1.475

3.  Phase II trial of PCNU in advanced malignant melanoma: an Eastern Cooperative Oncology Group pilot study.

Authors:  R H Earhart; F M Muggia; F M Golomb
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

Review 4.  Immunotoxin therapy of malignant melanoma.

Authors:  L E Spitler
Journal:  Med Oncol Tumor Pharmacother       Date:  1986

5.  Regional chemotherapy for melanoma. A 35-year experience.

Authors:  E T Krementz; R D Carter; C M Sutherland; J H Muchmore; R F Ryan; O Creech
Journal:  Ann Surg       Date:  1994-10       Impact factor: 12.969

6.  Treatment of advanced malignant melanoma with high-dose melphalan and autologous bone marrow transplantation.

Authors:  M A Cornbleet; T J McElwain; P J Kumar; J Filshie; P Selby; R L Carter; D W Hedley; M L Clark; J L Millar
Journal:  Br J Cancer       Date:  1983-09       Impact factor: 7.640

7.  Marrow autotransplantation accelerates haematological recovery in patients with malignant melanoma treated with high-dose melphalan.

Authors:  T J McElwain; D W Hedley; G Burton; H M Clink; M Y Gordon; M Jarman; C A Juttner; J L Millar; R A Milsted; G Prentice; I E Smith; D Spence; M Woods
Journal:  Br J Cancer       Date:  1979-07       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.